
About Raspberry Pharmaceuticals Private Limited
Data last updated:
Raspberry Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It was incorporated on 28 July 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U46497MP2023PTC066919.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ram Kailash Dangi and Prashant Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 136 Tapeshwari Bag, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.58 Lakh, a growth of 132% compared to the previous year. For the same year it recorded a net profit of ₹55,672 (net margin 2.1%) and EBITDA of ₹62,592 (EBITDA margin 2.4%).
The company is associated with 1 brand: Raspberry Pharma.
For more details, the company can be reached via its website raspberrypharma.com.
Company details
Contact details
Raspberry Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address136 Tapeshwari Bag, Indore, Madhya Pradesh, India – 452010
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Raspberry Pharmaceuticals operates one associated brand: Raspberry Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and manufacturing services in India. | raspberrypharma.com |
Business activity
The main business activity of Raspberry Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Raspberry Pharmaceuticals Private Limited, buy the company report.
Financials of Raspberry Pharmaceuticals Private Limited
FY 2025 filings availableRaspberry Pharmaceuticals Private Limited reported revenue of ₹26.58 Lakh (up 132% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 132% in the latest year. EBITDA rose 274% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹62,592 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹55,672 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.4% | |
| Net Profit Margin | 2.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Raspberry Pharmaceuticals Private Limited, buy the company report.
Board of directors of Raspberry Pharmaceuticals Private Limited
Raspberry Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Kailash Dangi | Director | 28 Jul 2023 | 3 Years 3 Months | Current |
| Prashant Gupta Also directs: Lincia Healthcare Private Limited | Director | 01 Dec 2025 | 0 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Raspberry Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raspberry Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Raspberry Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Raspberry Pharmaceuticals Private Limited has 6 board changes on record since 2023: 4 appointments and 2 cessations. The latest: Hariom Dangi ceased to be Director on 01 Dec 2025.
Frequently asked questions
Raspberry Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. It was incorporated on 28 July 2023 (3+ years old) and is registered under CIN U46497MP2023PTC066919.
Raspberry Pharmaceuticals has 2 current directors:
- Ram Kailash Dangi - Director
- Prashant Gupta - Director
The latest financial statements of Raspberry Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Raspberry Pharmaceuticals is U46497MP2023PTC066919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raspberry Pharmaceuticals was incorporated on 28 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
Hariom Dangi ceased to be Director on 01 Dec 2025. Prashant Gupta was appointed as Director on 01 Dec 2025. Hariom Dangi was appointed as Director on 03 Sep 2025. Raspberry Pharmaceuticals has 6 board changes on record in total.
Raspberry Pharmaceuticals can be reached through the website raspberrypharma.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Raspberry Pharmaceuticals is at 136 Tapeshwari Bag, Indore, Madhya Pradesh, India – 452010.
Raspberry Pharmaceuticals has 1 associated brand: Raspberry Pharma.
Raspberry Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.

